Musculoskeletal area
Muscle, bone, cartilage and tendon: the in vitro models used to document the effect of an ingredient or a supplement on strength, mobility and recovery.
Physiological areas
GastrointestinalMetabolism and cardiovascular systemDermatologicalNeurologicalOphthalmicMusculoskeletalRespiratoryOralUrologicalVaginalImmune systemWhat you can demonstrate here
Sarcopenia, bone density, joint discomfort, recovery after exertion. This is an area where the benefit is felt slowly and the market needs to tell the story before the consumer feels it. Here the effect is measured on the four tissues that determine mobility, with read-outs ranging from muscle trophism to bone mineralisation.
The models we use
What we measure
- Trophic effect on muscle cells
- Energy production in muscle cells
- NAD+/NADH ratio
- Markers of muscle senescence
- Muscle recovery: induced damage on myotubes, creatine kinase release, myoblast fusion index
- Osteoblast differentiation (ALP)
- Matrix mineralisation (Alizarin red)
- RANKL/OPG ratio
- Modulation of bone-specific markers
- Cell adhesion on titanium supports
- Anti-inflammatory activity on human chondrocytes
- Cytoprotection from oxidative stress in chondrocytes
- Collagen I and II production
- Chondrocyte viability
- Markers of inflammatory tendinopathy
- Protection of the tendon from inflammation
- Protection of the endothelium from oxidative stress
- Total antioxidant capacity (TEAC)
What is measured in this area
Muscle, bone, cartilage and tendon: the endpoints that document the effect of an ingredient on strength, mobility and recovery.
- Muscle protein synthesis — protein built in the myotube, measured directly
- Myoblast differentiation — formation and maturation of muscle fibres
- Catabolism and atrophy — markers of protein degradation under stimulus
- Osteoblast activity — proliferation and function of the cells that build bone
- Mineralisation — deposition of the mineral matrix over time
- Osteoclast activity — bone resorption, the other side of the same balance
- Type II collagen — the structural component of cartilage
- Joint inflammatory markers — cytokines and mediators released by joint cells
What you receive
- A report with model, protocol, controls and raw data
- Results per replicate, with mean and spread declared
- The balance between building and degradation, which is the figure that counts
- Behaviour over time where the process requires it, as in mineralisation
- A readable comparison between the conditions tested, usable in a technical dossier or in a conversation with a downstream customer
Who it is for, and where to start
- You are choosing between raw materials and need a measured criterion: ingredient validation and valorisation
- You have a finished product and want to know how much stays active in the formulation: supplement valorisation
- You need an ingredient that does not exist yet for this function: development of new ingredients
